Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11C-Acetate PET and 3T MRI in Prostate Cancer
NCT00924313Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbon-11 acetate in prostate cancer (PCa), sponsored by National Cancer Institute. Started Sep 2008; status: completed.
02
Drugs
carbon-11 acetate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00924313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924313.